AMERIPRISE FINANCIAL INC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$1,505,925
-53.9%
442,919
-0.4%
0.00%
-100.0%
Q2 2023$3,267,538
-14.6%
444,563
+20.4%
0.00%0.0%
Q1 2023$3,826,797
-33.8%
369,382
-24.6%
0.00%
-50.0%
Q4 2022$5,783,000
-38.1%
489,652
+10.1%
0.00%
-33.3%
Q3 2022$9,338,000
-18.7%
444,807
+20.2%
0.00%
-25.0%
Q2 2022$11,485,000
-23.2%
370,037
+1.6%
0.00%0.0%
Q1 2022$14,955,000
-7.5%
364,158
-2.1%
0.00%0.0%
Q4 2021$16,175,000
+178.2%
372,141
+220.5%
0.00%
+100.0%
Q3 2021$5,815,000
-7.5%
116,126
+16.3%
0.00%0.0%
Q2 2021$6,287,000
-26.2%
99,818
+8.9%
0.00%
-33.3%
Q1 2021$8,516,000
-1.0%
91,659
-4.6%
0.00%0.0%
Q4 2020$8,606,000
-29.2%
96,042
-18.4%
0.00%
-40.0%
Q3 2020$12,156,000
-38.2%
117,634
-52.7%
0.01%
-37.5%
Q2 2020$19,675,000
+21.4%
248,800
-11.2%
0.01%
-11.1%
Q1 2020$16,208,000
+10.3%
280,122
+2.9%
0.01%
+50.0%
Q4 2019$14,688,000
+0.7%
272,267
-2.5%
0.01%
-14.3%
Q3 2019$14,592,000
+3.5%
279,121
-4.4%
0.01%
+16.7%
Q2 2019$14,101,000
-22.4%
291,896
-18.9%
0.01%
-25.0%
Q1 2019$18,174,000
-20.8%
359,743
-7.1%
0.01%
-27.3%
Q4 2018$22,958,000
-4.1%
387,288
+6.5%
0.01%
+37.5%
Q3 2018$23,942,000
+75.1%
363,698
+34.3%
0.01%
+33.3%
Q2 2018$13,677,000
-7.7%
270,877
-3.8%
0.01%
-14.3%
Q1 2018$14,820,000
+13.7%
281,485
+0.4%
0.01%
+16.7%
Q4 2017$13,033,000
+15.9%
280,433
+0.9%
0.01%
+20.0%
Q3 2017$11,248,000
+20.5%
278,059
+1.0%
0.01%0.0%
Q2 2017$9,336,000
+45.0%
275,319
+24.2%
0.01%
+66.7%
Q1 2017$6,438,000
-8.8%
221,650
+3.2%
0.00%
-25.0%
Q4 2016$7,060,000
-1.8%
214,860
-6.9%
0.00%0.0%
Q3 2016$7,192,000
+18.3%
230,676
+6.6%
0.00%0.0%
Q2 2016$6,082,000
-72.8%
216,294
-64.8%
0.00%
-69.2%
Q1 2016$22,337,000
+155.4%
614,560
+181.1%
0.01%
+160.0%
Q4 2015$8,746,000
+103.9%
218,608
+45.2%
0.01%
+66.7%
Q3 2015$4,290,000
-13.1%
150,564
+0.7%
0.00%0.0%
Q2 2015$4,936,000
-27.7%
149,509
-37.0%
0.00%
-25.0%
Q1 2015$6,825,000
-14.7%
237,290
-19.3%
0.00%
-20.0%
Q4 2014$8,003,000
+51.3%
293,893
+18.4%
0.01%
+66.7%
Q3 2014$5,291,000
+76.7%
248,289
+86.3%
0.00%
+50.0%
Q2 2014$2,995,000
+1.0%
133,309
+13.6%
0.00%0.0%
Q1 2014$2,966,000
+13.4%
117,371
+3.2%
0.00%0.0%
Q4 2013$2,616,000
+25.1%
113,769
+3.6%
0.00%
+100.0%
Q3 2013$2,091,000
+51.6%
109,784
+14.8%
0.00%0.0%
Q2 2013$1,379,00095,6140.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders